| Name | Title | Contact Details |
|---|
For more than 130 years, Boehringer Ingelheim has been committed to the research, development, and manufacturing of new medications with high therapeutic value for people and animals. As a family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in research and development. We are proud of addressing some of the most challenging healthcare issues. Our vision – value through innovation – has always characterized our collaborative work, and is for us simultaneously a fundamental requirement and a driving force. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees.
EMSI Acquired Leprechaun is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Innovagraft Biologics is a Wayzata, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Optras Systems Pvt. is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.